Reflux Esophagitis (RE): Clinical Trials

5 trials for Reflux Esophagitis (RE), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 not yet recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Recruiting 2, Completed 1

Follow Reflux Esophagitis (RE): new trials by email Literature Review of Reflux Esophagitis (RE) trials Research Report on Reflux Esophagitis (RE)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study of Salivary Bile Acids and Pepsin as Predictive Biomarkers of Reflux Disease After Sleeve Gastrectomy
Reflux Disease, Gastro-Esophageal, Sleeve Gastrectomy
Not yet recruitingHospital de MatarĂ³602026-12-012026-05-26
A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.
Anaprazole + Rabeprazole placebo, Rabeprazole + Anaprazole placebo - Reflux Esophagitis (RE)
Phase 3RecruitingXuanzhu Biopharmaceutical Co., Ltd.5002025-07-302025-09-29
A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis
JP-1366 simulation tablets, Esomeprazole Magnesium (Nexium) simulation tablets - Reflux Esophagitis (RE)
Phase 3RecruitingLivzon Pharmaceutical Group Inc.3562024-12-052025-02-27
A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases
D961H sachet 10 mg, D961H capsule 10mg, D961H capsule 20 mg - Gastric Ulcer (GU), Duodenal Ulcer (DU)
Phase 3CompletedAstraZeneca552014-06-012017-01-19
Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of Life
Reflux Esophagitis (RE), Non-erosive Reflux Disease (NERD)
CompletedSeoul National University Bundang Hospital2072008-07-012012-02-20

Narrower conditions

Esophagitis, Peptic (5)  ·  Barrett Esophagus (1)  ·  Duodenal Ulcer (1)  ·  Gastroesophageal Reflux (1)  ·  Non-Erosive Reflux Disease (1)  ·  Stomach Ulcer (1)  ·  Zollinger-Ellison Syndrome (1)

Broader conditions

Digestive System Diseases (5)  ·  Duodenal Diseases (5)  ·  Esophageal Diseases (5)  ·  Esophagitis (5)  ·  Gastroenteritis (5)  ·  Gastrointestinal Diseases (5)  ·  Intestinal Diseases (5)  ·  Peptic Ulcer (5)  ·  Stomach Diseases (5)  ·  Deglutition Disorders (2)  ·  Esophageal Motility Disorders (2)  ·  Neoplasms (2)  ·  Digestive System Neoplasms (1)  ·  Gastroesophageal Reflux (1)  ·  Gastrointestinal Neoplasms (1)

Interventions

Esomeprazole (1)  ·  Rabeprazole (1)

Sponsors

AstraZeneca (1)  ·  Hospital de MatarĂ³ (1)  ·  Livzon Pharmaceutical Group Inc. (1)  ·  Seoul National University Bundang Hospital (1)  ·  Xuanzhu Biopharmaceutical Co., Ltd. (1)

Countries

China (2)  ·  Japan (1)  ·  South Korea (1)

Top investigators

Esther Mans Muntwyler, MD, PhD (1)